Table 3.

Time between diagnosis and start treatment and time between neoadjuvant chemotherapy and resection in gastric cancer patients stratified by period

	Time from diagnosis to start treatment in patients with potentially curable disease			Time from diagnosis to start treatment in patients with incurable disease			Time from diagnosis to direct resection in patients with potentially curable disease			Time from end of neoadjuvant chemo to resection in patients with potentially curable disease
	2017–2019	2020	p	2017–2019	2020	p	2017–2019	2020	p	2017–2019	2020	p
Week 1–8	6.60 (3.76)	6.23 (3.40)	0.397	5.14 (3.14)	5.86 (5.04)	0.186	7.85 (4.23)	7.18 (2.95)	0.500	7.31 (2.56)	6.57 (3.50)	0.128
Week 9–12	6.93 (4.40)	4.97 (3.92)	0.044	5.27 (6.29)	5.40 (3.23)	0.906	6.92 (3.31)	4.57 (4.75)	0.080	7.54 (3.40)	5.76 (1.48)	0.176
Week 13–17	7.48 (4.06)	6.22 (4.17)	0.116	5.63 (3.81)	4.96 (2.24)	0.416	9.33 (4.87)	6.56 (6.97)	0.170	7.50 (2.64)	7.59 (3.61)	0.914
Week 18–26	7.30 (5.12)	6.41 (2.98)	0.127	6.01 (4.84)	4.83 (3.52)	0.048	9.04 (6.24)	6.67 (3.55)	0.063	7.24 (2.51)	7.59 (2.76)	0.469
Week 27–53	7.22 (4.71)	6.62 (4.01)	0.060	5.50 (3.79)	4.86 (2.87)	0.020	7.96 (4.20)	7.54 (5.53)	0.505	7.24 (2.81)	7.36 (3.09)	0.671

Data for 2017–2019 are shown as the average of the 3 years. All data are reported in number of weeks, represented by mean (SD)